Back to FDA Applications sponsored by ALLERGAN HOLDINGS

FDA Drug Application 206940 by ALLERGAN HOLDINGS

Application Number206940
Application Type New Drug Application
Sponsor ApplicantALLERGAN HOLDINGS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/27/2015N42922000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206940Orig1s000ltr.pdf 5/28/2015
AP05/27/2015N42938000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf 5/29/2015
AP05/27/2015N43208000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206940Orig1s000TOC.cfm 7/2/2015
AP05/27/2015N43209000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206940Orig1s000SumR.pdf 7/2/2015
AP02/11/2016SLR45166001   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206940Orig1s001ltr.pdf 2/12/2016
AP02/11/2016SLR45201001   http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206940s001lbl.pdf 2/18/2016




Back to FDA Applications sponsored by ALLERGAN HOLDINGS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.